Inogen (INGN) EV to CFO (2014 - 2026)
Inogen's (INGN) quarterly EV to CFO came in at 22.7 in Q2 2026, up 45.93% year-over-year from 15.55 in Q2 2025, and up 357.43% quarter-over-quarter from 8.82 in Q1 2026.
Powered by 
Analysis
Inogen (INGN) EV to CFO (2014 - 2026) Analysis & Trends
Inogen (INGN) has reported EV to CFO for 13 consecutive years, with 22.7 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO rose 45.93% year-over-year to 22.7 in Q2 2026; TTM through Jun 2026 was 26.59, a 232.68% decrease from a year earlier, with the FY2025 full-year figure at 5.65, down 134.07% from the prior year.
- EV to CFO was 22.7 for Q2 2026 at Inogen, up from 8.82 in the prior quarter.
- Over five years, EV to CFO peaked at 59.53 in Q2 2022 and troughed at 67.26 in Q4 2025.
- A 5-year average of 2.34 and a median of 5.81 in 2025 frame the typical range for EV to CFO.
- The widest YoY moves for EV to CFO: up 310.58% in 2024, down 24584.67% in 2024.
- Over 5 years, EV to CFO stood at 15.9 in 2022, then soared by 100.84% to 0.13 in 2023, then plunged by 24584.67% to 32.52 in 2024, then plunged by 106.81% to 67.26 in 2025, then jumped by 133.75% to 22.7 in 2026.
- The last three EV to CFO figures came in at 22.7 (Q2 2026), 8.82 (Q1 2026), and 67.26 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.70 |
| Mar 31, 2026 | -8.82 |
| Dec 31, 2025 | -67.26 |
| Sep 30, 2025 | 45.49 |
| Jun 30, 2025 | 15.55 |
| Mar 31, 2025 | -4.12 |
| Dec 31, 2024 | -32.52 |
| Sep 30, 2024 | 15.79 |
| Jun 30, 2024 | 11.23 |
| Mar 31, 2024 | -14.79 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | -7.50 |
| Jun 30, 2023 | 19.92 |
| Mar 31, 2023 | -17.38 |
| Dec 31, 2022 | -15.90 |
| Sep 30, 2022 | -35.68 |
| Jun 30, 2022 | 59.53 |
| Mar 31, 2022 | -28.57 |
| Dec 31, 2021 | 81.16 |
| Sep 30, 2021 | -245.14 |